Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
15401
15402
15403
15404
15405
15406
15407
15408
15409
15410
15411
15412
15413
15414
15415
15416
15417
15418
15419
15420
15421
15422
15423
15424
15425
15426
15427
15428
15429
15430
15431
15432
15433
15434
15435
15436
15437
15438
15439
15440
15441
15442
15443
15444
15445
15446
15447
15448
15449
15450
15451
15452
15453
15454
15455
15456
15457
15458
15459
15460
15461
15462
15463
15464
15465
15466
15467
15468
15469
15470
15471
15472
15473
15474
15475
15476
15477
15478
15479
15480
15481
15482
15483
15484
15485
15486
15487
15488
15489
15490
15491
15492
15493
15494
15495
15496
15497
15498
15499
15500
15501
15502
15503
15504
15505
15506
15507
15508
15509
15510
15511
15512
15513
15514
15515
15516
15517
15518
15519
15520
15521
15522
15523
15524
15525
15526
15527
15528
15529
15530
15531
15532
15533
15534
15535
15536
15537
15538
15539
15540
15541
15542
15543
15544
15545
15546
15547
15548
15549
15550
15551
15552
15553
15554
15555
15556
15557
15558
15559
15560
15561
15562
15563
15564
15565
15566
15567
15568
15569
15570
15571
15572
15573
15574
15575
15576
15577
15578
15579
15580
15581
15582
15583
15584
15585
15586
15587
15588
15589
15590
15591
15592
15593
15594
15595
15596
15597
15598
15599
15600
| UnnamedSample_HQ_transcript/21733|m.7349 | UnnamedSample_HQ_transcript/21733 | Coverage 0.121 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF00178 | Ets-domain | 321 | 401 | 2.6E-30 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/42898|m.12460 | UnnamedSample_HQ_transcript/42898 | Coverage 0.232 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF02198 | Sterile alpha motif (SAM)/Pointed domain | 90 | 159 | 8.7E-20 | T | 22-09-2020 | IPR003118 | Pointed domain |
| UnnamedSample_HQ_transcript/42898|m.12460 | UnnamedSample_HQ_transcript/42898 | Coverage 0.232 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF00178 | Ets-domain | 321 | 401 | 2.6E-30 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/48098|m.13604 | UnnamedSample_HQ_transcript/48098 | Coverage 0.170 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF02198 | Sterile alpha motif (SAM)/Pointed domain | 90 | 159 | 8.7E-20 | T | 22-09-2020 | IPR003118 | Pointed domain |
| UnnamedSample_HQ_transcript/48098|m.13604 | UnnamedSample_HQ_transcript/48098 | Coverage 0.170 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF00178 | Ets-domain | 321 | 401 | 2.6E-30 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/36615|m.11075 | UnnamedSample_HQ_transcript/36615 | Coverage 0.151 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF02198 | Sterile alpha motif (SAM)/Pointed domain | 90 | 159 | 8.7E-20 | T | 22-09-2020 | IPR003118 | Pointed domain |
| UnnamedSample_HQ_transcript/36615|m.11075 | UnnamedSample_HQ_transcript/36615 | Coverage 0.151 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF00178 | Ets-domain | 321 | 401 | 2.6E-30 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/63725|m.16780 | UnnamedSample_HQ_transcript/63725 | Coverage 0.977 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF02198 | Sterile alpha motif (SAM)/Pointed domain | 90 | 159 | 8.7E-20 | T | 22-09-2020 | IPR003118 | Pointed domain |
| UnnamedSample_HQ_transcript/63725|m.16780 | UnnamedSample_HQ_transcript/63725 | Coverage 0.977 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF00178 | Ets-domain | 321 | 401 | 2.6E-30 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/51138|m.14273 | UnnamedSample_HQ_transcript/51138 | Coverage 0.203 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF02198 | Sterile alpha motif (SAM)/Pointed domain | 90 | 159 | 8.7E-20 | T | 22-09-2020 | IPR003118 | Pointed domain |
| UnnamedSample_HQ_transcript/51138|m.14273 | UnnamedSample_HQ_transcript/51138 | Coverage 0.203 too low. | ec10d7e3d824cc11d8cd211a74805d21 | 520 | Pfam | PF00178 | Ets-domain | 321 | 401 | 2.6E-30 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/99048|m.22502 | UnnamedSample_HQ_transcript/99048 | Coverage 0.878 too low. | 26ec276df2dcf61302d2616bb6843c2d | 346 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 51 | 148 | 3.5E-11 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/99048|m.22502 | UnnamedSample_HQ_transcript/99048 | Coverage 0.878 too low. | 26ec276df2dcf61302d2616bb6843c2d | 346 | Pfam | PF00372 | Hemocyanin, copper containing domain | 166 | 343 | 1.6E-38 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/43703|m.12642 | UnnamedSample_HQ_transcript/43703 | Unmapped. | bb50cfc1252f5b917463dc11a8fc815b | 200 | Pfam | PF02017 | CIDE-N domain | 6 | 77 | 6.1E-25 | T | 22-09-2020 | IPR003508 | CIDE-N domain |
| UnnamedSample_HQ_transcript/59148|m.15875 | UnnamedSample_HQ_transcript/59148 | Unmapped. | 97cdf4b6b8c37537e7cd1eb6e171a8ab | 376 | Pfam | PF10408 | Ubiquitin elongating factor core | 17 | 282 | 1.8E-89 | T | 22-09-2020 | IPR019474 | Ubiquitin conjugation factor E4, core |
| UnnamedSample_HQ_transcript/59148|m.15875 | UnnamedSample_HQ_transcript/59148 | Unmapped. | 97cdf4b6b8c37537e7cd1eb6e171a8ab | 376 | Pfam | PF04564 | U-box domain | 299 | 370 | 1.0E-30 | T | 22-09-2020 | IPR003613 | U box domain |
| UnnamedSample_HQ_transcript/85930|m.20639 | UnnamedSample_HQ_transcript/85930 | Coverage 0.122 too low. | 99560241b7e9faade0b2187e3d70b2b3 | 383 | Pfam | PF11732 | Transcription- and export-related complex subunit | 29 | 104 | 2.4E-24 | T | 22-09-2020 | IPR021726 | THO complex, subunitTHOC2, N-terminal |
| UnnamedSample_HQ_transcript/85930|m.20639 | UnnamedSample_HQ_transcript/85930 | Coverage 0.122 too low. | 99560241b7e9faade0b2187e3d70b2b3 | 383 | Pfam | PF11262 | Transcription factor/nuclear export subunit protein 2 | 335 | 378 | 1.0E-9 | T | 22-09-2020 | IPR021418 | THO complex, subunitTHOC2, C-terminal |
| UnnamedSample_HQ_transcript/66|m.66 | UnnamedSample_HQ_transcript/66 | Unmapped. | e8555dc5d1405ecbbc715b8cdc8bc5ee | 1880 | Pfam | PF13086 | AAA domain | 613 | 683 | 9.4E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/66|m.66 | UnnamedSample_HQ_transcript/66 | Unmapped. | e8555dc5d1405ecbbc715b8cdc8bc5ee | 1880 | Pfam | PF13087 | AAA domain | 796 | 954 | 3.5E-17 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/12338|m.4600 | UnnamedSample_HQ_transcript/12338 | Coverage 0.221 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF13202 | EF hand | 295 | 314 | 2.4E-4 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/12338|m.4600 | UnnamedSample_HQ_transcript/12338 | Coverage 0.221 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF13202 | EF hand | 220 | 234 | 0.047 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/12338|m.4600 | UnnamedSample_HQ_transcript/12338 | Coverage 0.221 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF13202 | EF hand | 332 | 353 | 0.0095 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/12338|m.4600 | UnnamedSample_HQ_transcript/12338 | Coverage 0.221 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF08022 | FAD-binding domain | 674 | 752 | 3.0E-16 | T | 22-09-2020 | IPR013112 | FAD-binding 8 |
| UnnamedSample_HQ_transcript/12338|m.4600 | UnnamedSample_HQ_transcript/12338 | Coverage 0.221 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF08030 | Ferric reductase NAD binding domain | 1030 | 1133 | 1.9E-12 | T | 22-09-2020 | IPR013121 | Ferric reductase, NAD binding domain |
| UnnamedSample_HQ_transcript/12338|m.4600 | UnnamedSample_HQ_transcript/12338 | Coverage 0.221 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF01794 | Ferric reductase like transmembrane component | 486 | 632 | 3.7E-25 | T | 22-09-2020 | IPR013130 | Ferric reductase transmembrane component-like domain |
| UnnamedSample_HQ_transcript/13576|m.4975 | UnnamedSample_HQ_transcript/13576 | Coverage 0.186 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF13202 | EF hand | 295 | 314 | 2.4E-4 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/13576|m.4975 | UnnamedSample_HQ_transcript/13576 | Coverage 0.186 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF13202 | EF hand | 220 | 234 | 0.047 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/13576|m.4975 | UnnamedSample_HQ_transcript/13576 | Coverage 0.186 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF13202 | EF hand | 332 | 353 | 0.0095 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/13576|m.4975 | UnnamedSample_HQ_transcript/13576 | Coverage 0.186 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF08022 | FAD-binding domain | 674 | 752 | 3.0E-16 | T | 22-09-2020 | IPR013112 | FAD-binding 8 |
| UnnamedSample_HQ_transcript/13576|m.4975 | UnnamedSample_HQ_transcript/13576 | Coverage 0.186 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF08030 | Ferric reductase NAD binding domain | 1030 | 1133 | 1.9E-12 | T | 22-09-2020 | IPR013121 | Ferric reductase, NAD binding domain |
| UnnamedSample_HQ_transcript/13576|m.4975 | UnnamedSample_HQ_transcript/13576 | Coverage 0.186 too low. | e05acc1925386fe8c538bcc9374625d6 | 1145 | Pfam | PF01794 | Ferric reductase like transmembrane component | 486 | 632 | 3.7E-25 | T | 22-09-2020 | IPR013130 | Ferric reductase transmembrane component-like domain |
| UnnamedSample_HQ_transcript/73559|m.18583 | UnnamedSample_HQ_transcript/73559 | Coverage 0.926 too low. | 26784141bbb33977bb423a9092720bec | 496 | Pfam | PF00012 | Hsp70 protein | 6 | 496 | 1.2E-237 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/23466|m.7798 | UnnamedSample_HQ_transcript/23466 | Coverage 0.802 too low. | de3f80e6d04ec5c0e5ba413ef6ac5812 | 685 | Pfam | PF03920 | Groucho/TLE N-terminal Q-rich domain | 1 | 76 | 2.7E-40 | T | 22-09-2020 | IPR005617 | Groucho/TLE, N-terminal Q-rich domain |
| UnnamedSample_HQ_transcript/23466|m.7798 | UnnamedSample_HQ_transcript/23466 | Coverage 0.802 too low. | de3f80e6d04ec5c0e5ba413ef6ac5812 | 685 | Pfam | PF00400 | WD domain, G-beta repeat | 493 | 517 | 0.15 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/23466|m.7798 | UnnamedSample_HQ_transcript/23466 | Coverage 0.802 too low. | de3f80e6d04ec5c0e5ba413ef6ac5812 | 685 | Pfam | PF00400 | WD domain, G-beta repeat | 395 | 426 | 0.09 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/23466|m.7798 | UnnamedSample_HQ_transcript/23466 | Coverage 0.802 too low. | de3f80e6d04ec5c0e5ba413ef6ac5812 | 685 | Pfam | PF00400 | WD domain, G-beta repeat | 523 | 559 | 0.0064 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/47751|m.13523 | UnnamedSample_HQ_transcript/47751 | Coverage 0.972 too low. | 24d4b063ab7b96b7f6f33eebe4cc9681 | 747 | Pfam | PF01576 | Myosin tail | 15 | 746 | 4.6E-110 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/9005|m.3515 | UnnamedSample_HQ_transcript/9005 | Identity 0.948 too low. | 1866caa7ecad20df8f2931b265767e84 | 1178 | Pfam | PF12872 | OST-HTH/LOTUS domain | 9 | 68 | 1.4E-7 | T | 22-09-2020 | IPR025605 | OST-HTH/LOTUS domain |
| UnnamedSample_HQ_transcript/9005|m.3515 | UnnamedSample_HQ_transcript/9005 | Identity 0.948 too low. | 1866caa7ecad20df8f2931b265767e84 | 1178 | Pfam | PF12872 | OST-HTH/LOTUS domain | 363 | 412 | 0.0024 | T | 22-09-2020 | IPR025605 | OST-HTH/LOTUS domain |
| UnnamedSample_HQ_transcript/9005|m.3515 | UnnamedSample_HQ_transcript/9005 | Identity 0.948 too low. | 1866caa7ecad20df8f2931b265767e84 | 1178 | Pfam | PF12872 | OST-HTH/LOTUS domain | 279 | 332 | 1.1E-4 | T | 22-09-2020 | IPR025605 | OST-HTH/LOTUS domain |
| UnnamedSample_HQ_transcript/9005|m.3515 | UnnamedSample_HQ_transcript/9005 | Identity 0.948 too low. | 1866caa7ecad20df8f2931b265767e84 | 1178 | Pfam | PF00567 | Tudor domain | 483 | 604 | 8.7E-19 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/99673|m.22584 | UnnamedSample_HQ_transcript/99673 | Coverage 0.554 too low. | 217e38e35944381e48db84a610174512 | 99 | Pfam | PF03051 | Peptidase C1-like family | 1 | 93 | 2.5E-44 | T | 22-09-2020 | IPR004134 | Peptidase C1B, bleomycin hydrolase |
| UnnamedSample_HQ_transcript/111682|m.24040 | UnnamedSample_HQ_transcript/111682 | Coverage 0.969 too low. | 217e38e35944381e48db84a610174512 | 99 | Pfam | PF03051 | Peptidase C1-like family | 1 | 93 | 2.5E-44 | T | 22-09-2020 | IPR004134 | Peptidase C1B, bleomycin hydrolase |
| UnnamedSample_HQ_transcript/105081|m.23238 | UnnamedSample_HQ_transcript/105081 | Coverage 0.489 too low. | 217e38e35944381e48db84a610174512 | 99 | Pfam | PF03051 | Peptidase C1-like family | 1 | 93 | 2.5E-44 | T | 22-09-2020 | IPR004134 | Peptidase C1B, bleomycin hydrolase |
| UnnamedSample_HQ_transcript/7834|m.3132 | UnnamedSample_HQ_transcript/7834 | Coverage 0.907 too low. | 8ea6c1661e222958db057586e64f2de3 | 1234 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 1041 | 1204 | 1.5E-62 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/76405|m.19098 | UnnamedSample_HQ_transcript/76405 | Coverage 0.343 too low. | 897b63207296c52ca50c73771cc64c7a | 182 | Pfam | PF00628 | PHD-finger | 126 | 171 | 4.4E-7 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/71628|m.18234 | UnnamedSample_HQ_transcript/71628 | Unmapped. | 50aed7bdbb6e0b1cc168c28fc94c0c35 | 181 | Pfam | PF02357 | Transcription termination factor nusG | 7 | 112 | 3.3E-27 | T | 22-09-2020 | IPR006645 | NusG, N-terminal |
| UnnamedSample_HQ_transcript/71628|m.18234 | UnnamedSample_HQ_transcript/71628 | Unmapped. | 50aed7bdbb6e0b1cc168c28fc94c0c35 | 181 | Pfam | PF00467 | KOW motif | 130 | 162 | 1.6E-7 | T | 22-09-2020 | IPR005824 | KOW |
| UnnamedSample_HQ_transcript/25897|m.8448 | UnnamedSample_HQ_transcript/25897 | Unmapped. | 51179578fe076287711f6da115535d00 | 860 | Pfam | PF08762 | CRPV capsid protein like | 673 | 824 | 1.4E-9 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/32616|m.10115 | UnnamedSample_HQ_transcript/32616 | Coverage 0.852 too low. | 8859a1d454327c41f80ae65dfae1eeb8 | 494 | Pfam | PF01388 | ARID/BRIGHT DNA binding domain | 148 | 233 | 6.7E-18 | T | 22-09-2020 | IPR001606 | ARID DNA-binding domain |
| UnnamedSample_HQ_transcript/10817|m.4088 | UnnamedSample_HQ_transcript/10817 | Coverage 0.700 too low. | 5ca4f3d2ec5ac4060b397c65d6bfb641 | 820 | Pfam | PF00571 | CBS domain | 709 | 756 | 1.5E-9 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/10817|m.4088 | UnnamedSample_HQ_transcript/10817 | Coverage 0.700 too low. | 5ca4f3d2ec5ac4060b397c65d6bfb641 | 820 | Pfam | PF00571 | CBS domain | 563 | 609 | 1.8E-5 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/10817|m.4088 | UnnamedSample_HQ_transcript/10817 | Coverage 0.700 too low. | 5ca4f3d2ec5ac4060b397c65d6bfb641 | 820 | Pfam | PF00571 | CBS domain | 636 | 682 | 9.1E-7 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/34554|m.10620 | UnnamedSample_HQ_transcript/34554 | Coverage 0.121 too low. | 6b4e19bbc0259aa8d2a86802f496befa | 531 | Pfam | PF00929 | Exonuclease | 366 | 517 | 2.1E-6 | T | 22-09-2020 | IPR013520 | Exonuclease, RNase T/DNA polymerase III |
| UnnamedSample_HQ_transcript/70333|m.17984 | UnnamedSample_HQ_transcript/70333 | Coverage 0.932 too low. | 20bb8c06c7a7a709460108c96cd06de4 | 531 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 52 | 511 | 3.3E-84 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/65268|m.17074 | UnnamedSample_HQ_transcript/65268 | Coverage 0.922 too low. | 20bb8c06c7a7a709460108c96cd06de4 | 531 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 52 | 511 | 3.3E-84 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/53508|m.14741 | UnnamedSample_HQ_transcript/53508 | Coverage 0.933 too low. | 20bb8c06c7a7a709460108c96cd06de4 | 531 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 52 | 511 | 3.3E-84 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/63099|m.16651 | UnnamedSample_HQ_transcript/63099 | Coverage 0.925 too low. | 20bb8c06c7a7a709460108c96cd06de4 | 531 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 52 | 511 | 3.3E-84 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/68212|m.17622 | UnnamedSample_HQ_transcript/68212 | Coverage 0.920 too low. | 20bb8c06c7a7a709460108c96cd06de4 | 531 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 52 | 511 | 3.3E-84 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/66180|m.17245 | UnnamedSample_HQ_transcript/66180 | Coverage 0.922 too low. | 20bb8c06c7a7a709460108c96cd06de4 | 531 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 52 | 511 | 3.3E-84 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/52497|m.14545 | UnnamedSample_HQ_transcript/52497 | Coverage 0.930 too low. | 20bb8c06c7a7a709460108c96cd06de4 | 531 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 52 | 511 | 3.3E-84 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/91413|m.21458 | UnnamedSample_HQ_transcript/91413 | Coverage 0.966 too low. | e044b4b426e8c69d527e800681307c02 | 345 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 30 | 85 | 2.7E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/91413|m.21458 | UnnamedSample_HQ_transcript/91413 | Coverage 0.966 too low. | e044b4b426e8c69d527e800681307c02 | 345 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 67 | 124 | 5.3E-10 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/91413|m.21458 | UnnamedSample_HQ_transcript/91413 | Coverage 0.966 too low. | e044b4b426e8c69d527e800681307c02 | 345 | Pfam | PF01410 | Fibrillar collagen C-terminal domain | 144 | 344 | 5.2E-56 | T | 22-09-2020 | IPR000885 | Fibrillar collagen, C-terminal |
| UnnamedSample_HQ_transcript/1454|m.832 | UnnamedSample_HQ_transcript/1454 | Coverage 0.982 too low. | 3efaff176f234dada7ae15d41110feb5 | 118 | Pfam | PF03226 | Yippee zinc-binding/DNA-binding /Mis18, centromere assembly | 16 | 112 | 3.2E-12 | T | 22-09-2020 | IPR004910 | Yippee/Mis18/Cereblon |
| UnnamedSample_HQ_transcript/3718|m.1699 | UnnamedSample_HQ_transcript/3718 | Coverage 0.969 too low. | 3efaff176f234dada7ae15d41110feb5 | 118 | Pfam | PF03226 | Yippee zinc-binding/DNA-binding /Mis18, centromere assembly | 16 | 112 | 3.2E-12 | T | 22-09-2020 | IPR004910 | Yippee/Mis18/Cereblon |
| UnnamedSample_HQ_transcript/56985|m.15443 | UnnamedSample_HQ_transcript/56985 | Coverage 0.920 too low. | 3efaff176f234dada7ae15d41110feb5 | 118 | Pfam | PF03226 | Yippee zinc-binding/DNA-binding /Mis18, centromere assembly | 16 | 112 | 3.2E-12 | T | 22-09-2020 | IPR004910 | Yippee/Mis18/Cereblon |
| UnnamedSample_HQ_transcript/42478|m.12367 | UnnamedSample_HQ_transcript/42478 | Coverage 0.060 too low. | fbfcefcc652e51150577b0fbad8d2fd9 | 453 | Pfam | PF15898 | cGMP-dependent protein kinase interacting domain | 353 | 453 | 2.9E-33 | T | 22-09-2020 | IPR031775 | cGMP-dependent protein kinase, interacting domain |
| UnnamedSample_HQ_transcript/8781|m.3445 | UnnamedSample_HQ_transcript/8781 | Coverage 0.838 too low. | cf30a1d696adadd68ca543b91d1884a2 | 915 | Pfam | PF18861 | Transmembrane domain of protein tyrosine phosphatase, receptor type J | 440 | 580 | 1.1E-18 | T | 22-09-2020 | IPR041201 | PTPRJ, transmembrane domain |
| UnnamedSample_HQ_transcript/8781|m.3445 | UnnamedSample_HQ_transcript/8781 | Coverage 0.838 too low. | cf30a1d696adadd68ca543b91d1884a2 | 915 | Pfam | PF00041 | Fibronectin type III domain | 322 | 404 | 5.8E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/8781|m.3445 | UnnamedSample_HQ_transcript/8781 | Coverage 0.838 too low. | cf30a1d696adadd68ca543b91d1884a2 | 915 | Pfam | PF00041 | Fibronectin type III domain | 231 | 298 | 1.5E-8 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/8781|m.3445 | UnnamedSample_HQ_transcript/8781 | Coverage 0.838 too low. | cf30a1d696adadd68ca543b91d1884a2 | 915 | Pfam | PF00102 | Protein-tyrosine phosphatase | 654 | 883 | 1.5E-77 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/13954|m.5098 | UnnamedSample_HQ_transcript/13954 | Unmapped. | ba156a79ed7ed3c8caa62c5ad63b9ce9 | 1226 | Pfam | PF08762 | CRPV capsid protein like | 1046 | 1197 | 1.8E-9 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/64300|m.16909 | UnnamedSample_HQ_transcript/64300 | Coverage 0.507 too low. | f014fffaa7682a028278de89cff17ab2 | 527 | Pfam | PF00096 | Zinc finger, C2H2 type | 162 | 183 | 6.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/64300|m.16909 | UnnamedSample_HQ_transcript/64300 | Coverage 0.507 too low. | f014fffaa7682a028278de89cff17ab2 | 527 | Pfam | PF00096 | Zinc finger, C2H2 type | 346 | 368 | 0.0025 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/64300|m.16909 | UnnamedSample_HQ_transcript/64300 | Coverage 0.507 too low. | f014fffaa7682a028278de89cff17ab2 | 527 | Pfam | PF00096 | Zinc finger, C2H2 type | 402 | 424 | 1.2E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/64300|m.16909 | UnnamedSample_HQ_transcript/64300 | Coverage 0.507 too low. | f014fffaa7682a028278de89cff17ab2 | 527 | Pfam | PF00096 | Zinc finger, C2H2 type | 374 | 396 | 3.3E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/64300|m.16909 | UnnamedSample_HQ_transcript/64300 | Coverage 0.507 too low. | f014fffaa7682a028278de89cff17ab2 | 527 | Pfam | PF00096 | Zinc finger, C2H2 type | 430 | 452 | 0.0024 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/64300|m.16909 | UnnamedSample_HQ_transcript/64300 | Coverage 0.507 too low. | f014fffaa7682a028278de89cff17ab2 | 527 | Pfam | PF00096 | Zinc finger, C2H2 type | 318 | 340 | 0.0046 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/64300|m.16909 | UnnamedSample_HQ_transcript/64300 | Coverage 0.507 too low. | f014fffaa7682a028278de89cff17ab2 | 527 | Pfam | PF00096 | Zinc finger, C2H2 type | 458 | 480 | 0.0024 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/83739|m.20307 | UnnamedSample_HQ_transcript/83739 | Coverage 0.942 too low. | f3ef486845ae67ff8cb4fb77473be5e5 | 407 | Pfam | PF06990 | Galactose-3-O-sulfotransferase | 23 | 346 | 9.7E-47 | T | 22-09-2020 | IPR009729 | Galactose-3-O-sulfotransferase |
| UnnamedSample_HQ_transcript/44007|m.12719 | UnnamedSample_HQ_transcript/44007 | Identity 0.653 too low. | 58344964690f900cc67dd11e000def69 | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/44007|m.12719 | UnnamedSample_HQ_transcript/44007 | Identity 0.653 too low. | 58344964690f900cc67dd11e000def69 | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 3.9E-6 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00053 | Laminin EGF domain | 587 | 642 | 1.5E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00053 | Laminin EGF domain | 503 | 527 | 1.7E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00053 | Laminin EGF domain | 112 | 160 | 4.2E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00053 | Laminin EGF domain | 537 | 584 | 5.0E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00053 | Laminin EGF domain | 745 | 789 | 3.1E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00053 | Laminin EGF domain | 645 | 695 | 3.3E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00053 | Laminin EGF domain | 203 | 247 | 1.7E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00053 | Laminin EGF domain | 698 | 742 | 2.6E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00053 | Laminin EGF domain | 251 | 299 | 2.1E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00053 | Laminin EGF domain | 792 | 831 | 4.0E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF06009 | Laminin Domain II | 1293 | 1415 | 8.4E-10 | T | 22-09-2020 | IPR010307 | Laminin domain II |
| UnnamedSample_HQ_transcript/386|m.299 | UnnamedSample_HQ_transcript/386 | Coverage 0.276 too low. | 9c658836b687d0bebdd9ba9b76b10dc4 | 1461 | Pfam | PF00052 | Laminin B (Domain IV) | 367 | 502 | 7.0E-23 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/74948|m.18825 | UnnamedSample_HQ_transcript/74948 | Coverage 0.739 too low. | 603fb604ff086cbacb24cd4cd35be9d4 | 450 | Pfam | PF00501 | AMP-binding enzyme | 66 | 420 | 8.0E-62 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/88419|m.21003 | UnnamedSample_HQ_transcript/88419 | Identity 0.910 too low. | 2c18663e192753e644c4575c27410649 | 241 | Pfam | PF00149 | Calcineurin-like phosphoesterase | 87 | 237 | 6.8E-28 | T | 22-09-2020 | IPR004843 | Calcineurin-like phosphoesterase domain, ApaH type |
| UnnamedSample_HQ_transcript/88419|m.21003 | UnnamedSample_HQ_transcript/88419 | Identity 0.910 too low. | 2c18663e192753e644c4575c27410649 | 241 | Pfam | PF16891 | Serine-threonine protein phosphatase N-terminal domain | 24 | 84 | 5.0E-6 | T | 22-09-2020 | IPR031675 | Serine-threonine protein phosphatase, N-terminal |
| UnnamedSample_HQ_transcript/42010|m.12262 | UnnamedSample_HQ_transcript/42010 | Coverage 0.958 too low. | 5be9aa3a89199ca9552bd8c03e82c500 | 273 | Pfam | PF07679 | Immunoglobulin I-set domain | 164 | 234 | 5.0E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/69816|m.17894 | UnnamedSample_HQ_transcript/69816 | Coverage 0.386 too low. | e1a813f698038b45acd027b395cae5d7 | 499 | Pfam | PF15361 | Resistance to inhibitors of cholinesterase homologue 3 | 210 | 334 | 1.6E-10 | T | 22-09-2020 | IPR032763 | Resistance to inhibitors of cholinesterase protein 3, N-terminal |
| UnnamedSample_HQ_transcript/62761|m.16588 | UnnamedSample_HQ_transcript/62761 | Coverage 0.530 too low. | 8c4785851e33ec579e4daffd92d85af8 | 525 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 30 | 503 | 8.9E-97 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/24120|m.7977 | UnnamedSample_HQ_transcript/24120 | Coverage 0.513 too low. | 922e953d3b9ae224aab85b704c808937 | 994 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 281 | 528 | 4.0E-44 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/29884|m.9452 | UnnamedSample_HQ_transcript/29884 | Coverage 0.618 too low. | 48b564bc685567e876bdc8e733a92d31 | 787 | Pfam | PF07766 | LETM1-like protein | 146 | 410 | 7.2E-103 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/16633|m.5900 | UnnamedSample_HQ_transcript/16633 | Coverage 0.691 too low. | 48b564bc685567e876bdc8e733a92d31 | 787 | Pfam | PF07766 | LETM1-like protein | 146 | 410 | 7.2E-103 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/32046|m.9961 | UnnamedSample_HQ_transcript/32046 | Coverage 0.201 too low. | 0626bf905fa4cbac141cb5619b670850 | 533 | Pfam | PF00929 | Exonuclease | 368 | 519 | 2.1E-6 | T | 22-09-2020 | IPR013520 | Exonuclease, RNase T/DNA polymerase III |
| UnnamedSample_HQ_transcript/40596|m.11977 | UnnamedSample_HQ_transcript/40596 | Identity 0.753 too low. | fd3ed36cf8cdae97401e4760805548c1 | 469 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 146 | 403 | 5.8E-115 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/88153|m.20958 | UnnamedSample_HQ_transcript/88153 | Coverage 0.757 too low. | 86618fd630576c5aae99253299748b14 | 287 | Pfam | PF08445 | FR47-like protein | 198 | 276 | 8.2E-15 | T | 22-09-2020 | IPR013653 | FR47-like |
| UnnamedSample_HQ_transcript/88153|m.20958 | UnnamedSample_HQ_transcript/88153 | Coverage 0.757 too low. | 86618fd630576c5aae99253299748b14 | 287 | Pfam | PF18713 | Domain of unknown function (DUF5645) | 8 | 122 | 8.7E-9 | T | 22-09-2020 | IPR041506 | Domain of unknown function DUF5645 |
| UnnamedSample_HQ_transcript/98360|m.22415 | UnnamedSample_HQ_transcript/98360 | Coverage 0.885 too low. | 86618fd630576c5aae99253299748b14 | 287 | Pfam | PF08445 | FR47-like protein | 198 | 276 | 8.2E-15 | T | 22-09-2020 | IPR013653 | FR47-like |
| UnnamedSample_HQ_transcript/98360|m.22415 | UnnamedSample_HQ_transcript/98360 | Coverage 0.885 too low. | 86618fd630576c5aae99253299748b14 | 287 | Pfam | PF18713 | Domain of unknown function (DUF5645) | 8 | 122 | 8.7E-9 | T | 22-09-2020 | IPR041506 | Domain of unknown function DUF5645 |
| UnnamedSample_HQ_transcript/26782|m.8672 | UnnamedSample_HQ_transcript/26782 | Coverage 0.960 too low. | 16be6fef953fcb371d6d262c95a12e66 | 473 | Pfam | PF12063 | Domain of unknown function (DUF3543) | 311 | 451 | 7.0E-15 | T | 22-09-2020 | IPR022708 | Serine/threonine-protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/60910|m.16240 | UnnamedSample_HQ_transcript/60910 | Coverage 0.319 too low. | 3ec8f167109799c930bb463472da03c7 | 278 | Pfam | PF00102 | Protein-tyrosine phosphatase | 47 | 271 | 6.2E-43 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 957 | 1067 | 2.2E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 849 | 952 | 2.3E-37 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 391 | 446 | 1.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 294 | 350 | 9.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 230 | 285 | 2.8E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 456 | 510 | 1.6E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 332 | 389 | 4.4E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 145 | 201 | 6.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 200 | 258 | 1.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 781 | 837 | 1.1E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 81 | 139 | 4.3E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 731 | 788 | 2.6E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/1229|m.736 | UnnamedSample_HQ_transcript/1229 | Coverage 0.812 too low. | 07c52263a6da58fe16dc185dfce1082c | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 47 | 99 | 4.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6915|m.2833 | UnnamedSample_HQ_transcript/6915 | Coverage 0.932 too low. | 81e1c8eee40c1ad84e147472499aa527 | 942 | Pfam | PF00435 | Spectrin repeat | 3 | 93 | 1.2E-14 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/6915|m.2833 | UnnamedSample_HQ_transcript/6915 | Coverage 0.932 too low. | 81e1c8eee40c1ad84e147472499aa527 | 942 | Pfam | PF00435 | Spectrin repeat | 633 | 739 | 2.1E-18 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/6915|m.2833 | UnnamedSample_HQ_transcript/6915 | Coverage 0.932 too low. | 81e1c8eee40c1ad84e147472499aa527 | 942 | Pfam | PF00435 | Spectrin repeat | 97 | 206 | 2.7E-14 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/6915|m.2833 | UnnamedSample_HQ_transcript/6915 | Coverage 0.932 too low. | 81e1c8eee40c1ad84e147472499aa527 | 942 | Pfam | PF00435 | Spectrin repeat | 743 | 839 | 9.0E-13 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/6915|m.2833 | UnnamedSample_HQ_transcript/6915 | Coverage 0.932 too low. | 81e1c8eee40c1ad84e147472499aa527 | 942 | Pfam | PF00435 | Spectrin repeat | 209 | 311 | 2.0E-25 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/6915|m.2833 | UnnamedSample_HQ_transcript/6915 | Coverage 0.932 too low. | 81e1c8eee40c1ad84e147472499aa527 | 942 | Pfam | PF00435 | Spectrin repeat | 315 | 416 | 4.5E-23 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/6915|m.2833 | UnnamedSample_HQ_transcript/6915 | Coverage 0.932 too low. | 81e1c8eee40c1ad84e147472499aa527 | 942 | Pfam | PF00435 | Spectrin repeat | 849 | 941 | 5.4E-15 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/6915|m.2833 | UnnamedSample_HQ_transcript/6915 | Coverage 0.932 too low. | 81e1c8eee40c1ad84e147472499aa527 | 942 | Pfam | PF00435 | Spectrin repeat | 421 | 522 | 5.2E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/6915|m.2833 | UnnamedSample_HQ_transcript/6915 | Coverage 0.932 too low. | 81e1c8eee40c1ad84e147472499aa527 | 942 | Pfam | PF00435 | Spectrin repeat | 527 | 630 | 1.8E-17 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/107488|m.23520 | UnnamedSample_HQ_transcript/107488 | Coverage 0.987 too low. | 83d99d64672c80bdd057c6c235051008 | 169 | Pfam | PF14604 | Variant SH3 domain | 29 | 82 | 2.5E-12 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/107488|m.23520 | UnnamedSample_HQ_transcript/107488 | Coverage 0.987 too low. | 83d99d64672c80bdd057c6c235051008 | 169 | Pfam | PF14604 | Variant SH3 domain | 119 | 167 | 2.1E-17 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/120995|m.24925 | UnnamedSample_HQ_transcript/120995 | Unmapped. | 2895fd59df7f2eab17c582918ab50922 | 197 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 39 | 196 | 1.2E-12 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/13659|m.5004 | UnnamedSample_HQ_transcript/13659 | Coverage 0.050 too low. | 157f2d8b8ccb47c80a707610e98616c9 | 380 | Pfam | PF02188 | GoLoco motif | 55 | 75 | 1.7E-8 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/13659|m.5004 | UnnamedSample_HQ_transcript/13659 | Coverage 0.050 too low. | 157f2d8b8ccb47c80a707610e98616c9 | 380 | Pfam | PF02145 | Rap/ran-GAP | 300 | 374 | 8.5E-27 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/15856|m.5664 | UnnamedSample_HQ_transcript/15856 | Identity 0.810 too low. | 64282f37967a3603e749049f6c4d1e9c | 351 | Pfam | PF03360 | Glycosyltransferase family 43 | 126 | 323 | 2.2E-62 | T | 22-09-2020 | IPR005027 | Glycosyl transferase, family 43 |
| UnnamedSample_HQ_transcript/38105|m.11421 | UnnamedSample_HQ_transcript/38105 | Coverage 0.988 too low. | 64282f37967a3603e749049f6c4d1e9c | 351 | Pfam | PF03360 | Glycosyltransferase family 43 | 126 | 323 | 2.2E-62 | T | 22-09-2020 | IPR005027 | Glycosyl transferase, family 43 |
| UnnamedSample_HQ_transcript/39495|m.11742 | UnnamedSample_HQ_transcript/39495 | Coverage 0.137 too low. | 4c15ccdb66a7b7f52ce01114932da4e7 | 650 | Pfam | PF15035 | Ciliary rootlet component, centrosome cohesion | 25 | 223 | 1.1E-62 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6981|m.2853 | UnnamedSample_HQ_transcript/6981 | Coverage 0.813 too low. | 4b27845abf76d737aba14bcccf2304ee | 1019 | Pfam | PF00412 | LIM domain | 484 | 539 | 3.6E-13 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/4705|m.2073 | UnnamedSample_HQ_transcript/4705 | Coverage 0.077 too low. | 248f863b50a2e6a6e4b09a3de570520f | 1046 | Pfam | PF12203 | Glutamine rich N terminal domain of histone deacetylase 4 | 52 | 135 | 2.9E-6 | T | 22-09-2020 | IPR024643 | Histone deacetylase, glutamine rich N-terminal domain |
| UnnamedSample_HQ_transcript/4705|m.2073 | UnnamedSample_HQ_transcript/4705 | Coverage 0.077 too low. | 248f863b50a2e6a6e4b09a3de570520f | 1046 | Pfam | PF00850 | Histone deacetylase domain | 633 | 950 | 2.6E-85 | T | 22-09-2020 | IPR023801 | Histone deacetylase domain |
| UnnamedSample_HQ_transcript/60178|m.16095 | UnnamedSample_HQ_transcript/60178 | Identity 0.937 too low. | 8ed66d97db52ced4a8aee8b43622c79f | 528 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 87 | 506 | 1.4E-92 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/4974|m.2184 | UnnamedSample_HQ_transcript/4974 | Coverage 0.925 too low. | a57e7c8d5a71012cf25512e1d608ec54 | 900 | Pfam | PF00018 | SH3 domain | 769 | 812 | 1.8E-13 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/4974|m.2184 | UnnamedSample_HQ_transcript/4974 | Coverage 0.925 too low. | a57e7c8d5a71012cf25512e1d608ec54 | 900 | Pfam | PF00620 | RhoGAP domain | 542 | 692 | 9.6E-45 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/4974|m.2184 | UnnamedSample_HQ_transcript/4974 | Coverage 0.925 too low. | a57e7c8d5a71012cf25512e1d608ec54 | 900 | Pfam | PF00611 | Fes/CIP4, and EFC/F-BAR homology domain | 37 | 118 | 4.7E-16 | T | 22-09-2020 | IPR001060 | FCH domain |
| UnnamedSample_HQ_transcript/78641|m.19488 | UnnamedSample_HQ_transcript/78641 | Coverage 0.824 too low. | 989fd6cd340d109b8a8dc0af5706a3b3 | 443 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/41623|m.12186 | UnnamedSample_HQ_transcript/41623 | Identity 0.780 too low. | 827e472a58cfab5b78af2f838ffbbe16 | 349 | Pfam | PF03166 | MH2 domain | 121 | 328 | 8.2E-71 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/33411|m.10316 | UnnamedSample_HQ_transcript/33411 | Identity 0.801 too low. | 827e472a58cfab5b78af2f838ffbbe16 | 349 | Pfam | PF03166 | MH2 domain | 121 | 328 | 8.2E-71 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/36771|m.11107 | UnnamedSample_HQ_transcript/36771 | Identity 0.793 too low. | 827e472a58cfab5b78af2f838ffbbe16 | 349 | Pfam | PF03166 | MH2 domain | 121 | 328 | 8.2E-71 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/54|m.55 | UnnamedSample_HQ_transcript/54 | Identity 0.944 too low. | cf5cce37c29ea04a5dfc5f76b24d3fef | 3244 | Pfam | PF00094 | von Willebrand factor type D domain | 2695 | 2833 | 2.0E-6 | T | 22-09-2020 | IPR001846 | von Willebrand factor, type D domain |
| UnnamedSample_HQ_transcript/54|m.55 | UnnamedSample_HQ_transcript/54 | Identity 0.944 too low. | cf5cce37c29ea04a5dfc5f76b24d3fef | 3244 | Pfam | PF01347 | Lipoprotein amino terminal region | 3 | 431 | 7.2E-42 | T | 22-09-2020 | IPR001747 | Lipid transport protein, N-terminal |
| UnnamedSample_HQ_transcript/54|m.55 | UnnamedSample_HQ_transcript/54 | Identity 0.944 too low. | cf5cce37c29ea04a5dfc5f76b24d3fef | 3244 | Pfam | PF09172 | Domain of unknown function (DUF1943) | 463 | 770 | 5.4E-51 | T | 22-09-2020 | IPR015255 | Vitellinogen, open beta-sheet |
| UnnamedSample_HQ_transcript/50601|m.14148 | UnnamedSample_HQ_transcript/50601 | Coverage 0.364 too low. | 276a2fa7d961d1f43616fd9782701ade | 421 | Pfam | PF15997 | Domain of unknown function (DUF4772) | 5 | 120 | 1.3E-33 | T | 22-09-2020 | IPR031940 | Domain of unknown function DUF4772 |
| UnnamedSample_HQ_transcript/10450|m.3970 | UnnamedSample_HQ_transcript/10450 | Unmapped. | 1224da75687f8064775eb96eedd69008 | 1193 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 827 | 1152 | 1.2E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/17184|m.6064 | UnnamedSample_HQ_transcript/17184 | Coverage 0.868 too low. | 7c4bc696b6a49a94dcd71358d0c839f6 | 1021 | Pfam | PF00630 | Filamin/ABP280 repeat | 547 | 633 | 1.1E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/17184|m.6064 | UnnamedSample_HQ_transcript/17184 | Coverage 0.868 too low. | 7c4bc696b6a49a94dcd71358d0c839f6 | 1021 | Pfam | PF00630 | Filamin/ABP280 repeat | 830 | 916 | 8.3E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/17184|m.6064 | UnnamedSample_HQ_transcript/17184 | Coverage 0.868 too low. | 7c4bc696b6a49a94dcd71358d0c839f6 | 1021 | Pfam | PF00630 | Filamin/ABP280 repeat | 79 | 163 | 4.3E-9 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/17184|m.6064 | UnnamedSample_HQ_transcript/17184 | Coverage 0.868 too low. | 7c4bc696b6a49a94dcd71358d0c839f6 | 1021 | Pfam | PF00630 | Filamin/ABP280 repeat | 174 | 259 | 2.0E-9 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/17184|m.6064 | UnnamedSample_HQ_transcript/17184 | Coverage 0.868 too low. | 7c4bc696b6a49a94dcd71358d0c839f6 | 1021 | Pfam | PF00630 | Filamin/ABP280 repeat | 264 | 349 | 8.3E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/17184|m.6064 | UnnamedSample_HQ_transcript/17184 | Coverage 0.868 too low. | 7c4bc696b6a49a94dcd71358d0c839f6 | 1021 | Pfam | PF00630 | Filamin/ABP280 repeat | 737 | 822 | 3.0E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/17184|m.6064 | UnnamedSample_HQ_transcript/17184 | Coverage 0.868 too low. | 7c4bc696b6a49a94dcd71358d0c839f6 | 1021 | Pfam | PF00630 | Filamin/ABP280 repeat | 363 | 444 | 1.6E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/17184|m.6064 | UnnamedSample_HQ_transcript/17184 | Coverage 0.868 too low. | 7c4bc696b6a49a94dcd71358d0c839f6 | 1021 | Pfam | PF00630 | Filamin/ABP280 repeat | 924 | 1013 | 4.5E-17 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/8876|m.3473 | UnnamedSample_HQ_transcript/8876 | Coverage 0.092 too low. | 7ee9d0b6577a708c013c8e3ae45fa3a0 | 1291 | Pfam | PF00096 | Zinc finger, C2H2 type | 840 | 861 | 0.0076 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/8876|m.3473 | UnnamedSample_HQ_transcript/8876 | Coverage 0.092 too low. | 7ee9d0b6577a708c013c8e3ae45fa3a0 | 1291 | Pfam | PF00096 | Zinc finger, C2H2 type | 200 | 221 | 7.3E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/8876|m.3473 | UnnamedSample_HQ_transcript/8876 | Coverage 0.092 too low. | 7ee9d0b6577a708c013c8e3ae45fa3a0 | 1291 | Pfam | PF00096 | Zinc finger, C2H2 type | 133 | 155 | 0.002 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/8876|m.3473 | UnnamedSample_HQ_transcript/8876 | Coverage 0.092 too low. | 7ee9d0b6577a708c013c8e3ae45fa3a0 | 1291 | Pfam | PF00096 | Zinc finger, C2H2 type | 78 | 99 | 0.0023 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/11759|m.4414 | UnnamedSample_HQ_transcript/11759 | Coverage 0.290 too low. | bd0ff863cafa74359c104edf2b482c8a | 789 | Pfam | PF00090 | Thrombospondin type 1 domain | 274 | 322 | 7.4E-10 | T | 22-09-2020 | IPR000884 | Thrombospondin type-1 (TSP1) repeat |
| UnnamedSample_HQ_transcript/11759|m.4414 | UnnamedSample_HQ_transcript/11759 | Coverage 0.290 too low. | bd0ff863cafa74359c104edf2b482c8a | 789 | Pfam | PF00090 | Thrombospondin type 1 domain | 331 | 378 | 1.1E-4 | T | 22-09-2020 | IPR000884 | Thrombospondin type-1 (TSP1) repeat |
| UnnamedSample_HQ_transcript/11759|m.4414 | UnnamedSample_HQ_transcript/11759 | Coverage 0.290 too low. | bd0ff863cafa74359c104edf2b482c8a | 789 | Pfam | PF00791 | ZU5 domain | 591 | 687 | 4.4E-29 | T | 22-09-2020 | IPR000906 | ZU5 domain |
| UnnamedSample_HQ_transcript/11759|m.4414 | UnnamedSample_HQ_transcript/11759 | Coverage 0.290 too low. | bd0ff863cafa74359c104edf2b482c8a | 789 | Pfam | PF07679 | Immunoglobulin I-set domain | 179 | 261 | 1.8E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/54529|m.14952 | UnnamedSample_HQ_transcript/54529 | Coverage 0.417 too low. | d824ebfa38d49a401909bf674c772b39 | 621 | Pfam | PF12738 | twin BRCT domain | 21 | 80 | 3.3E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/54529|m.14952 | UnnamedSample_HQ_transcript/54529 | Coverage 0.417 too low. | d824ebfa38d49a401909bf674c772b39 | 621 | Pfam | PF12738 | twin BRCT domain | 117 | 178 | 1.6E-13 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/54529|m.14952 | UnnamedSample_HQ_transcript/54529 | Coverage 0.417 too low. | d824ebfa38d49a401909bf674c772b39 | 621 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 308 | 382 | 2.8E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/54529|m.14952 | UnnamedSample_HQ_transcript/54529 | Coverage 0.417 too low. | d824ebfa38d49a401909bf674c772b39 | 621 | Pfam | PF16589 | BRCT domain, a BRCA1 C-terminus domain | 492 | 573 | 1.7E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/2954|m.1429 | UnnamedSample_HQ_transcript/2954 | Coverage 0.798 too low. | 8ce3bc2d74272b6574170cc434fb6fba | 1159 | Pfam | PF00595 | PDZ domain | 80 | 152 | 1.3E-7 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/2954|m.1429 | UnnamedSample_HQ_transcript/2954 | Coverage 0.798 too low. | 8ce3bc2d74272b6574170cc434fb6fba | 1159 | Pfam | PF00595 | PDZ domain | 246 | 325 | 2.0E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/2954|m.1429 | UnnamedSample_HQ_transcript/2954 | Coverage 0.798 too low. | 8ce3bc2d74272b6574170cc434fb6fba | 1159 | Pfam | PF00595 | PDZ domain | 803 | 892 | 1.1E-17 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/2954|m.1429 | UnnamedSample_HQ_transcript/2954 | Coverage 0.798 too low. | 8ce3bc2d74272b6574170cc434fb6fba | 1159 | Pfam | PF00595 | PDZ domain | 1055 | 1128 | 1.6E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/2954|m.1429 | UnnamedSample_HQ_transcript/2954 | Coverage 0.798 too low. | 8ce3bc2d74272b6574170cc434fb6fba | 1159 | Pfam | PF00595 | PDZ domain | 433 | 502 | 3.0E-9 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/2|m.3 | UnnamedSample_HQ_transcript/2 | Unmapped. | 4d5302567f4069576ccda0b859b846f0 | 1250 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 43 | 411 | 1.9E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/2|m.3 | UnnamedSample_HQ_transcript/2 | Unmapped. | 4d5302567f4069576ccda0b859b846f0 | 1250 | Pfam | PF13087 | AAA domain | 995 | 1166 | 1.0E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/2|m.3 | UnnamedSample_HQ_transcript/2 | Unmapped. | 4d5302567f4069576ccda0b859b846f0 | 1250 | Pfam | PF13086 | AAA domain | 812 | 882 | 5.8E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/85548|m.20578 | UnnamedSample_HQ_transcript/85548 | Coverage 0.888 too low. | 6223865e12156395a0bc92a6421860ea | 439 | Pfam | PF14911 | S-phase genomic integrity recombination mediator, C-terminal | 57 | 429 | 1.1E-70 | T | 22-09-2020 | IPR029424 | MMS22-like, C-terminal |
| UnnamedSample_HQ_transcript/76950|m.19195 | UnnamedSample_HQ_transcript/76950 | Coverage 0.357 too low. | c900104cf955b38a25190db55c6d1ba9 | 377 | Pfam | PF12998 | Inhibitor of growth proteins N-terminal histone-binding | 3 | 103 | 6.5E-27 | T | 22-09-2020 | IPR024610 | Inhibitor of growth protein, N-terminal histone-binding |
| UnnamedSample_HQ_transcript/89986|m.21254 | UnnamedSample_HQ_transcript/89986 | Coverage 0.268 too low. | c900104cf955b38a25190db55c6d1ba9 | 377 | Pfam | PF12998 | Inhibitor of growth proteins N-terminal histone-binding | 3 | 103 | 6.5E-27 | T | 22-09-2020 | IPR024610 | Inhibitor of growth protein, N-terminal histone-binding |
| UnnamedSample_HQ_transcript/17370|m.6115 | UnnamedSample_HQ_transcript/17370 | Coverage 0.617 too low. | fc54a59ef7a313e55c3d80e57f7d5a84 | 804 | Pfam | PF19056 | WD40 repeated domain | 443 | 658 | 2.5E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/105025|m.23233 | UnnamedSample_HQ_transcript/105025 | Coverage 0.982 too low. | b133d9e7187df5c595f471046aab38c1 | 218 | Pfam | PF07690 | Major Facilitator Superfamily | 7 | 207 | 2.8E-11 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/48616|m.13718 | UnnamedSample_HQ_transcript/48616 | Identity 0.745 too low. | f938faaa2c5ed4e3f5a293b9821a22ec | 517 | Pfam | PF00412 | LIM domain | 461 | 515 | 5.6E-13 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/48616|m.13718 | UnnamedSample_HQ_transcript/48616 | Identity 0.745 too low. | f938faaa2c5ed4e3f5a293b9821a22ec | 517 | Pfam | PF00412 | LIM domain | 343 | 398 | 1.5E-16 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/48616|m.13718 | UnnamedSample_HQ_transcript/48616 | Identity 0.745 too low. | f938faaa2c5ed4e3f5a293b9821a22ec | 517 | Pfam | PF00412 | LIM domain | 402 | 456 | 3.8E-14 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/48616|m.13718 | UnnamedSample_HQ_transcript/48616 | Identity 0.745 too low. | f938faaa2c5ed4e3f5a293b9821a22ec | 517 | Pfam | PF00412 | LIM domain | 284 | 338 | 2.9E-17 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/45463|m.13021 | UnnamedSample_HQ_transcript/45463 | Identity 0.787 too low. | f938faaa2c5ed4e3f5a293b9821a22ec | 517 | Pfam | PF00412 | LIM domain | 461 | 515 | 5.6E-13 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/45463|m.13021 | UnnamedSample_HQ_transcript/45463 | Identity 0.787 too low. | f938faaa2c5ed4e3f5a293b9821a22ec | 517 | Pfam | PF00412 | LIM domain | 343 | 398 | 1.5E-16 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/45463|m.13021 | UnnamedSample_HQ_transcript/45463 | Identity 0.787 too low. | f938faaa2c5ed4e3f5a293b9821a22ec | 517 | Pfam | PF00412 | LIM domain | 402 | 456 | 3.8E-14 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/45463|m.13021 | UnnamedSample_HQ_transcript/45463 | Identity 0.787 too low. | f938faaa2c5ed4e3f5a293b9821a22ec | 517 | Pfam | PF00412 | LIM domain | 284 | 338 | 2.9E-17 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
